External Quality Assurance Schemes (EQUASs) and Inter-laboratory Comparison Investigations (ICIs) for human biomonitoring of polycyclic aromatic hydrocarbon (PAH) biomarkers in urine as part of the quality assurance programme under HBM4EU.
暂无分享,去创建一个
J. Antignac | A. Sakhi | H. Koch | T. Göen | S. Nübler | Darina Dvořáková | J. Hajšlová | K. Vorkamp | A. Castaño | Max Scherer | Karin Haji-Abbas-Zarrabi | M. Schäfer | K. Urbancová | Therese Burkhardt | J. Pulkrabová | M. Esteban López | H. Mol | Johannes Müller
[1] Marta Esteban López,et al. Interlaboratory Comparison Investigations (ICIs) and External Quality Assurance Schemes (EQUASs) for human biomonitoring of perfluoroalkyl substances (PFASs) in serum as part of the quality assurance programme under HBM4EU. , 2022, The Science of the total environment.
[2] Marta Esteban López,et al. Interlaboratory Comparison Investigations (ICIs) for human biomonitoring of chromium as part of the quality assurance programme under HBM4EU , 2021, Journal of Trace Elements in Medicine and Biology.
[3] M. Vrijheid,et al. HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity – The HBM4EU survey , 2021, International journal of hygiene and environmental health.
[4] J. Antignac,et al. The European human biomonitoring platform - Design and implementation of a laboratory quality assurance/quality control (QA/QC) programme for selected priority chemicals. , 2021, International journal of hygiene and environmental health.
[5] Marta Esteban López,et al. Interlaboratory comparison investigations (ICI) and external quality assurance schemes (EQUAS) for cadmium in urine and blood: Results from the HBM4EU project. , 2021, International journal of hygiene and environmental health.
[6] A. Branscum,et al. Trends in urinary metabolites of polycyclic aromatic hydrocarbons (PAHs) in the non-smoking U.S. population, NHANES 2001-2014. , 2021, Chemosphere.
[7] J. Vondráček,et al. The role of metabolism in toxicity of polycyclic aromatic hydrocarbons and their non-genotoxic modes of action. , 2020, Current drug metabolism.
[8] J. Antignac,et al. Biomarkers, matrices and analytical methods targeting human exposure to chemicals selected for a European human biomonitoring initiative. , 2020, Environment international.
[9] R. Sram,et al. Comparison of polycyclic aromatic hydrocarbon metabolite concentrations in urine of mothers and their newborns. , 2020, The Science of the total environment.
[10] Paula Alvito,et al. Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future. , 2019, International journal of hygiene and environmental health.
[11] H. Drexler,et al. Naphthalene [BAT Value Documentation, 2018] , 2018 .
[12] T. Göen,et al. Reliable quantification of 1,2-dihydroxynaphthalene in urine using a conjugated reference compound for calibration , 2017, Analytical and Bioanalytical Chemistry.
[13] Erik Lebret,et al. Human biomonitoring as a tool to support chemicals regulation in the European Union. , 2017, International journal of hygiene and environmental health.
[14] É. Gaudreau,et al. Stability issues in the determination of 19 urinary (free and conjugated) monohydroxy polycyclic aromatic hydrocarbons , 2016, Analytical and Bioanalytical Chemistry.
[15] A. Castaño,et al. Urinary polycyclic aromatic hydrocarbon metabolites levels in a representative sample of the Spanish adult population: The BIOAMBIENT.ES project. , 2015, Chemosphere.
[16] J. Parrott,et al. Forensic source differentiation of petrogenic, pyrogenic, and biogenic hydrocarbons in Canadian oil sands environmental samples. , 2014, Journal of hazardous materials.
[17] Ki-Hyun Kim,et al. A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects. , 2013, Environment international.
[18] P. Souček,et al. Exposure to polycyclic aromatic hydrocarbons in women from Poland, Serbia and Italy – relation between PAH metabolite excretion, DNA damage, diet and genotype (the EU DIEPHY project) , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[19] M. McClean,et al. Excretion profiles and half-lives of ten urinary polycyclic aromatic hydrocarbon metabolites after dietary exposure. , 2012, Chemical research in toxicology.
[20] N. Benowitz,et al. Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. , 2012, Chemical research in toxicology.
[21] Thomas Göen,et al. External quality assessment of human biomonitoring in the range of environmental exposure levels. , 2012, International journal of hygiene and environmental health.
[22] S. Burchiel,et al. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. , 2010, IARC monographs on the evaluation of carcinogenic risks to humans.
[23] L. Knudsen,et al. Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies--a review. , 2008, International journal of hygiene and environmental health.
[24] S. Caudill,et al. Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population. , 2008, Environmental research.
[25] Ranjeet S. Sokhi,et al. Atmospheric polycyclic aromatic hydrocarbons: Source attribution, emission factors and regulation , 2008 .
[26] K. Hayakawa,et al. Simultaneous determination of urinary hydroxylated metabolites of naphthalene, fluorene, phenanthrene, fluoranthene and pyrene as multiple biomarkers of exposure to polycyclic aromatic hydrocarbons , 2006, Analytical and bioanalytical chemistry.
[27] Lovisa C. Romanoff,et al. Automated solid-phase extraction method for measuring urinary polycyclic aromatic hydrocarbon metabolites in human biomonitoring using isotope-dilution gas chromatography high-resolution mass spectrometry. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[28] Michael Thompson,et al. The International Harmonized Protocol for the proficiency testing of analytical chemistry laboratories (IUPAC Technical Report) , 2006 .
[29] C. Schulz,et al. German Environmental Survey 1998 (GerES III): environmental pollutants in the urine of the German population. , 2003, International journal of hygiene and environmental health.
[30] T Fearn,et al. A new test for 'sufficient homogeneity'. , 2001, The Analyst.
[31] Michael Thompson,et al. Recent trends in inter-laboratory precision at ppb and sub-ppb concentrations in relation to fitness for purpose criteria in proficiency testing , 2000 .
[32] T. Göen,et al. The elimination of 1-hydroxypyrene in the urine of the general population and workers with different occupational exposures to PAH. , 1995, The Science of the total environment.
[33] G. Grimmer,et al. Biomonitoring of polycyclic aromatic hydrocarbons in highly exposed coke plant workers by measurement of urinary phenanthrene and pyrene metabolites (phenols and dihydrodiols) , 1993, International archives of occupational and environmental health.